---
$id: https://graph.org.ai/services/class/85445600
$type: ServiceClass
source: UNSPSC
code: "85445600"
title: "Diagnoses of drugs primarily affecting the autonomic nervous system"
family: "85440000"
familyTitle: "Diagnoses of external causes of morbidity and mortality"
segment: "85000000"
segmentTitle: "Healthcare Services"
---

# Diagnoses of drugs primarily affecting the autonomic nervous system

**UNSPSC Code**: 85445600
**Family**: [Diagnoses of external causes of morbidity and mortality](Diagnoses of external causes of morbidity and mortality.mdx)
**Segment**: [Healthcare Services](../Healthcare Services.mdx)

In this classification, this covers the group of activities that yields a diagnosis of drugs primarily affecting the autonomic nervous system. Drugs primarily affecting the autonomic nervous system is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y51. ICD-10 also has The following Drugs primarily affecting the autonomic nervous system children in its four-character category: Y51.0 (Anticholinesterase agents); Y51.1 (Other parasympathomimetics [cholinergics]); Y51.2 (Ganglionic blocking drugs, not elsewhere classified); Y51.3 (Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified); Y51.4 (Predominantly alpha-adrenoreceptor agonists, not elsewhere classified); Y51.5 (Predominantly beta-adrenoreceptor agonists, not elsewhere classified); Y51.6 (Alpha-adrenoreceptor antagonists, not elsewhere classified); Y51.7 (Beta-adrenoreceptor antagonists, not elsewhere classified); Y51.8 (Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified); Y51.9 (Other and unspecified drugs primarily affecting the autonomic nervous system)

## Commodities

Browse the folders below to explore commodities in this class.
